MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Todays Market
- Indian Stock Market Updates March 13, 2020
AUROBINDO PHARMA Surges by 10%; BSE HEALTHCARE Index Up 0.4%
Fri, 13 Mar 10:51 AM
AUROBINDO PHARMA share price has zoomed 10% and is presently trading at Rs 412.
Meanwhile, the BSE HEALTHCARE Index is at 12,298 (up 0.4%).
Among the top Gainers in the BSE HEALTHCARE Index today is AUROBINDO PHARMA (up 10.0%).
NARAYANA HRUDAYALAYA LTD and SUN PHARMA ADV. RES. (down 0.4%) are among the top losers today.
Over the last one year, AUROBINDO PHARMA has moved down from Rs 773 to Rs 412, registering a loss of Rs 361 (down 46.7%).
On the other hand, the BSE HEALTHCARE has moved down from 14,333 to 12,298, loss of 2,035 points (down 14.2%) during the last 12 months.
The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 90.4%), DR. LAL PATHLABS LTD (up 48.9%) and J.B.CHEMICALS (up 48.8%).
JUST IN: Limited-Time Access to Full Transcript of Our Urgent Broadcast on India's Revival
What About the Benchmark Indices?
The BSE Sensex is at 32,392 (down 1.3%).
The top gainers among the BSE Sensex stocks today are SUN PHARMA (up 7.4%), HDFC (up 1.7%) and BAJAJ FINANCE (up 0.7%). Other gainers include BHARTI AIRTEL (up 0.4%) and ICICI BANK (up 0.3%). The most traded stocks in the BSE Sensex are HDFC BANK and ICICI BANK.
In the meantime, NSE Nifty is at 9,520 (down 1.0%). SUN PHARMA (up 7.7%) is among the top gainers in NSE Nifty.
Over the last 12 months, the BSE Sensex has moved down from 37,536 to 32,392, registering a loss of 5,144 points (down 13.8%).
AUROBINDO PHARMA Financial Update...
AUROBINDO PHARMA net profit down at Rs 7 billion for the quarter ended December 2019, compared to a loss of Rs 7 billion a year ago. Net Sales rose 10.1% to Rs 58.0 billion during the period as against Rs 52.7 billion in October-December 2018.
For the year ended March 2019, AUROBINDO PHARMA reported 1.2% increase in net profit to Rs 24.5 billion compared to net profit of Rs 24.2 billion during FY18.
Revenue of the company grew 18.6% to Rs 196 billion during FY19.
The current Price to earnings ratio of AUROBINDO PHARMA, based on rolling 12 month earnings, stands at 9.4x.
Indian Share Market Update: Top Gainers and Losers
What else is happening in the markets today? Dig in...
- TRACK NOW:
- Most Active Stocks Rs 0 to 10
- Most Active Stocks Rs 10 to 20
- Top Gainers Today BSE A Group
- Top Gainers Today NSE Above Rs 20
- Top Gainers Today BSE Above Rs 20
- Top Gainers Today BSE Sensex
- Top Gainers Today BSE Small Cap
- Top Gainers Today BSE 500
- Top Losers Today BSE A Group
- Most Active Stocks Rs 1 to 2
- Top Losers Today NSE Above Rs 20
- Buzzing Stocks Today
- Most Popular Stocks BSE 30
- TRENDING ON EQUITYMASTER:
- Warren Buffett - The Value Investor
- Your Ultimate Guide to Penny Stock Investing
- How to Invest in Gold
- Basics of Value Investing
- Benjamin Graham
- The Best Bluechip Stocks to Buy
- How to Invest in Silver
- The Best Small-cap Stocks to Buy
- 10 Rules for Successful Long-Term Investing
- How to Invest in the Share Market
- Best Stocks to Buy Today
- How to Use P/E for Successful Investing
- How to Find Undervalued Stocks
- Differences Between Trading and Investing
- SWOT Analysis for Stocks
- The Best Dividend Stocks to Buy
Stock Market Updates
Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers (Today's Market)
Apr 16, 2021 ClosingIndian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.
P&G HYGIENE at All Time High; BSE FMCG Index Up 0.5% (Today's Market)
Apr 16, 2021 03:34 PMP&G HYGIENE share price has hit an all time high at Rs 14,100 (up 3.1%). The BSE FMCG Index is up by 0.5%. Among the top gainers in the BSE FMCG Index today are P&G HYGIENE (up 3.1%) and NESTLE (up 2.0%). The top losers include HUL and GILLETTE INDIA (down 0.1%).
Sensex Trades Marginally Higher, Dow Futures Down by 28 Points (Today's Market)
Apr 16, 2021 12:30 pmBSE Sensex is trading up by 74 points, while the NSE Nifty is trading up by 55 points.
Indian Share Markets Open Marginally Higher; Wipro Up 7% Post Q4 Results (Today's Market)
Apr 16, 2021 09:30 amIndian share markets open in green. The BSE Sensex opened up by 131 points, while the Nifty is trading higher by 40 points.
DCM SHRIRAM Share Price Up by 10%; BSE 500 Index Up 0.6% (Today's Market)
Apr 16, 2021 09:54 AMDCM SHRIRAM share price is trading up by 10% and its current market price is Rs 619. The BSE 500 is up by 0.6%. The top gainers in the BSE 500 Index is DCM SHRIRAM (up 10.3%). The top losers are GODREJ PROPERTIES and TVS SRICHAKRA .
HINDUSTAN COPPER Share Price Up by 5%; BSE METAL Index Up 0.8% (Today's Market)
Apr 16, 2021 09:34 AMHINDUSTAN COPPER share price is trading up by 5% and its current market price is Rs 145. The BSE METAL is up by 0.8%. The top gainers in the BSE METAL Index is HINDUSTAN COPPER (up 5.2%). The top losers is COAL INDIA (down 0.2%).
View More Indian Share Market NewsMost Popular
India: Recovery Stalled by Vaccine Games?(The Honest Truth)
Apr 13, 2021Ajit Dayal on how India's vaccine strategy will impact the markets.
4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)
Apr 6, 2021Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)
Apr 15, 2021Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
Why Did the Market Crash on Monday?(Fast Profits Daily)
Apr 13, 2021In this video, I'll you what I think is the real reason behind yesterday's market crash.
A Unique Sector for Short-Term Profits(Fast Profits Daily)
Apr 12, 2021This ignored sector could deliver big short-term profits.
MoreOUR TOP 5 IDEAS
- Free Report: Multibagger Stock Ideas 2021
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
- Free Report: The Secret to Increasing Your Trading Profits Daily!
- No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.
S&P BSE SENSEX
Apr 16, 2021 (Close)
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
- Basics of Value Investing
- Benjamin Graham
- How to Invest in Gold
- How to Invest in Silver
- Best Stocks to Buy Today
- Warren Buffett - The Value Investor
- The Best Small-cap Stocks to Buy
- The Best Bluechip Stocks to Buy
- Your Ultimate Guide to Penny Stock Investing
- 10 Rules for Successful Long-Term Investing
- How to Invest in the Share Market
- Momentum Moves
FOLLOW
APP
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster requests your view! Post a comment on "AUROBINDO PHARMA Surges by 10%; BSE HEALTHCARE Index Up 0.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!